NEW YORK, November 2, 2017 /PRNewswire/ --
If you want a Stock Review on CVRS, AEMD, ALGN, or AVGR then come overto http://dailystocktracker.com/register/ and sign up for your free customized report. This morning, DailyStockTracker.com scans the following: Corindus Vascular Robotics Inc. (NYSE AMER: CVRS), Aethlon Medical Inc. (NASDAQ: AEMD), Align Technology
Corindus Vascular Robotics
Waltham, Massachusetts headquartered Corindus Vascular Robotics Inc.'s stock finished Wednesday's session 13.18% lower at $0.99. A total volume of 1.27 million shares was traded, which was above their three months average volume of 598,090 shares. The Company's shares have advanced 41.71% since the start of this year. The stock is trading below its 200-day moving average by 24.48%. Moreover, shares of the Company, which designs, manufactures, and sells robotic-assisted precision vascular intervention systems for use in interventional vascular procedures, have a Relative Strength Index (RSI) of 24.81.
On October 24th, 2017, Corindus Vascular Robotics announced that it will release financial and business results for Q2 2017 after the close of trading on November 07th, 2017. The management team will host a conference call at 4:30 p.m. ET that same day to discuss the results and recent business developments. The webcast may be accessed under the "Investor Relations" section of the Company's website. Your complete research report on CVRS can be retrieved for free at:
Shares in San Diego, California-based Aethlon Medical Inc. declined 0.72%, ending yesterday's session at $0.97 with a total trading volume of 165,145 shares. The stock has gained 1.05% in the past month. The Company's shares are trading 29.62% below their 50-day moving average. Moreover, shares of Aethlon Medical have an RSI of 43.53.
On October 30th, 2017, Aethlon Medical announced that it will issue financial results for Q2 FY18 ended September 30th, 2017 at 4:15 p.m. ET on November 02nd, 2017. Management will host a conference call at 4:30 p.m. ET that same day to review the results and corporate highlights. The conference call will be webcast live and available on the Company's website. A free report on AEMD is just a click away at:
On Wednesday, San Jose, California headquartered Align Technology Inc.'s stock saw a decline of 1.69%, to close the day at $234.95. A total volume of 1.44 million shares was traded, which was above their three months average volume of 963,210 shares. The Company's shares have surged 26.01% in the last one month, 37.83% in the previous three months, and 144.41% on an YTD basis. The stock is trading 24.16% and 61.90% above its 50-day and 200-day moving averages, respectively. Additionally, shares of Align Technology, which designs, manufactures, and markets a system of clear aligner therapy, intra-oral scanners, and computer-aided design and computer-aided manufacturing digital services, have an RSI of 83.89.
On October 23rd, 2017, research firm Stifel reiterated its 'Buy' rating on the Company's stock with an increase of the target price from $205 a share to $225 a share.
On November 01st, 2017, Align Technology announced the opening of its 2018 Research Award Program to support clinical and scientific dental research in universities across the globe. This year, up to $300,000 will be awarded to university faculty for scientific and technological research initiatives to advance patient care in the fields of orthodontics and dentistry. Research proposals and completed applications must be received by 5:00 p.m. PST on March 02nd, 2018. Award recipients will be notified by June 01st, 2018. Sign up for your complimentary research report on ALGN at:
Shares in Redwood City, California headquartered Avinger Inc. ended the day 2.12% higher at $0.33. A total volume of 3.67 million shares was traded, which was above their three months average volume of 1.63 million shares. The stock has gained 8.86% in the last one month. The Company's shares are trading above their 50-day moving average by 5.43%. Furthermore, shares of Avinger have an RSI of 49.81.
On October 31st, 2017, Avinger announced that it will release financial results for Q3 2017 after the close of trading on November 09th, 2017. The Company will host a corresponding conference call, beginning at 4:30 p.m. ET that same day. A live webcast of the call will be available under the investor relations section of the Company's website. Register for free on DailyStockTracker.com and download the latest research report on AVGR at:
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
DST has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number: (207)331-3313 Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
Subscribe to our Free Newsletters!
The state health insurance programs provide health care support to the below poverty line (BPL) ...
There is a lining between the lungs and chest wall known as Pleura. The dismissal of pleura by a ...
Reflux nephropathy is the scarring and damage caused to the kidneys by reverse flow of urine from ...View All